Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Ranibizumab for Type 1 ROP
NCT03148132Phase 4Completed
- Sponsor
- Universidad Autónoma de San Luis Potosí
- Start
- May 2017
- Primary completion
- Aug 2018
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in retinopathy of prematurity (ROP), sponsored by Universidad Autónoma de San Luis Potosí. Started May 2017; status: completed.
02
Drugs
ranibizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT03148132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148132.